Atria Investments’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-32,970
Closed -$5.6M – 615
2020
Q2
$5.6M Buy
+32,970
New +$4.92M 0.19% 134
2020
Q1
– Sell
-3,964
Closed -$453K – 1240
2019
Q4
$453K Sell
3,964
-86
-2% -$9.12K 0.01% 823
2019
Q3
$346K Sell
4,050
-14
-0.3% -$1.03K 0.01% 676
2019
Q2
$315K Sell
4,064
-206
-5% -$14.4K 0.01% 726
2019
Q1
$313K Buy
+4,270
New +$304K 0.01% 688
2018
Q4
– Sell
-3,738
Closed -$288K – 1035
2018
Q3
$288K Buy
3,738
+287
+8% +$21.1K 0.01% 781
2018
Q2
$229K Buy
+3,451
New +$198K 0.01% 844
2017
Q4
– Sell
-5,714
Closed -$311K – 887
2017
Q3
$311K Buy
5,714
+287
+5% +$14.7K 0.02% 597
2017
Q2
$281K Buy
5,427
+1,220
+29% +$77.5K 0.02% 581
2017
Q1
$264K Buy
4,207
+143
+4% +$8.93K 0.02% 565
2016
Q4
$214K Buy
+4,064
New +$244K 0.02% 585

Other funds holding SGEN

Atria Investments's SGEN Position: Q3 2020 in Review

Atria Investments sold out of Seagen Inc. Common Stock (SGEN) in Q3 2020, closing a stake of 32,970 shares — an estimated $5.6M sold.

Atria Investments first reported a position in SGEN in Q4 2016 and held it in 11 quarters. The position peaked at $5.6M in Q2 2020. 435 funds tracked by Wall St. Rank hold SGEN as of Q3 2020.

  • Atria Investments reported no remaining Seagen Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Atria Investments sold 32,970 Seagen Inc. Common Stock shares in Q3 2020, an estimated $5.6M.
  • Atria Investments first reported a position in Seagen Inc. Common Stock in Q4 2016 and held it in 11 quarters.
  • Atria Investments's Seagen Inc. Common Stock position peaked at $5.6M in Q2 2020.
  • 435 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2020.

Based on Atria Investments's 13F filing for Q3 2020, filed 5 Nov 2020.